IMIQUIMOD
Generic: IMIQUIMOD
Sun Pharmaceutical IndustriesManufacturer
TOPICALRoute
IMIQUIMODActive Substance
2021-01-26Original Approval
IMIQUIMOD is FDA application ANDA205971, sponsored by TARO. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
OFF LABEL USE
246 reports
2
PRODUCT USE IN UNAPPROVED INDICATION
172 reports
3
DRUG INEFFECTIVE
154 reports
4
ERYTHEMA
142 reports
5
FATIGUE
128 reports
6
PAIN
120 reports
7
APPLICATION SITE ERYTHEMA
82 reports
8
NAUSEA
79 reports
9
PRURITUS
70 reports
10
HEADACHE
64 reports